Glaxosmithkline

Rs 10 lakh penalty imposed on Glaxo Smith Kline for misleading ad

The Central Consumer Protection Authority (CCPA) has imposed a penalty of Rs 10 lakh each on Glaxo Smith Kline and Naaptol for misleading advertisements of their products.

GlaxoSmithKline Pharma Q2 net up 3% to Rs 193 cr, revenue down to Rs 906 cr

GlaxoSmithKline Pharmaceuticals on Friday said its net profit increased 3 per cent to Rs 193 crore in the second quarter ended September. The drug maker had reported a net profit from continuing operations at Rs 187 crore in the July-September period of the previous fiscal. However, revenue from operations declined to Rs 906 crore in the second quarter of the current fiscal compared to Rs 916 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing. "GSK India has delivered another quarter of strong performance in general medicines and specialty business, gaining market share. We hope to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth," GlaxoSmithKline Pharmaceuticals Managing Director Sridhar Venkatesh said. Vaccines business was impacted due to low vaccination rates as the overall market for the self-pay segment in which the company operates continues to decline, he ...

India-made cervical cancer vaccine Ceravac to cost Rs 200-400 per dose

Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices

Glaxosmithkline Pharma Q1 consolidated net profit up 8% at Rs 116 crore

Drug manufacturers GlaxoSmithKline on Monday said its consolidated net profit increased to Rs 116 crore in the first quarter. Shares of the company closed at Rs 1,726.20 on BSE, said reports

Unilever faces fresh pressure over margins as it backs down on M&A

Unilever sees 2022 underlying sales growth of 4.5%-6.5%, announces 3-bn euro buyback

CCI approves deal involving three GlaxoSmithKline group entities

The proposed deal involves the transfer of GlaxoSmithKline Asia Pvt Ltd's products and GSK Consumer Brands (indirectly) to GSK CH HoldCo

Covid: GSK says tests show antibody drug works against Omicron variant

Sotrovimab, developed with Vir, tested in lab, on hamsters; key mutations of Omicron did not elude drug activity in study

At $54-bn value, interest in GSK's arm may lead to biggest-ever buyout

Advent International, CVC Capital Partners and KKR are among potential suitors for GSK's consumer unit

GlaxoSmithKline Pharma Q1 net profit up 9% at Rs 121 crore

Drug firm GlaxoSmithKline Pharmaceuticals on Monday reported a 9.24 per cent rise in consolidated net profit to Rs 121.08 crore for the quarter ended June 30, 2021.

GSK says it aims to bring FDA-approved antibody therapy to India for Covid

Treatment with Sotrovimab resulted in an 85 per cent reduction in the risk of hospitalization, says company.

Glaxo gets ready for next pandemic after hiccups in Covid vaccine

Pharma giant is talking with the UK and other governments about building facilities to bring vaccine development onshore before the next crisis.

GSK, Sanofi begin new Covid-19 vaccine trial after setback last year

If the results are conclusive, the two drugmakers hope to see the vaccine approved by the fourth quarter after having initially targeted the first half of this year

GlaxoSmithKline Pharmaceuticals reports net profit of Rs 157 cr in Q3

GlaxoSmithKline Pharmaceuticals on Friday said it has registered a consolidated net profit of Rs 156.51 crore for the third quarter ended December

UnitedHealth Group names former Glaxo CEO Witty to lead company

UnitedHealth Group is promoting former GlaxoSmithKline leader Sir Andrew Witty to become the health insurance provider's next CEO immediately.

Sanofi, GSK to supply Covax with 200 million doses of coronavirus vaccine

Sanofi and GSK have signed a Statement of Intent with Gavi, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual Covid-19 vaccines.

Equity fund raising rises 88% to $32.7 bn in first 9 months of 2020

This is already a record year for amount mobilised through the equity capital markets (ECM), topping $31.2 billion raised during calendar 2007, according to financial data firm Refinitiv

GlaxoSmithKline CEO optimistic Covid-19 vaccine widely available in 2021

The group's most advanced project is with French partner Sanofi and the two have said they hope to get approval for their candidate next year

Covid-19 vaccine makers must deliver to US in time to get full payments

The Cambridge, Massachusetts, biotech's $1.5-billion deal pays out in full if its vaccine receives regulatory clearance by January 31, 2021

US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'

The US government previously gave Moderna around $1 billion to fund its research efforts, bringing total US funding to around $2.5 billion

US FDA approves GlaxoSmithKline's experimental drug for blood cancer

Multiple myeloma is the second most common form of blood cancer in the US and is generally considered treatable, but not curable